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Abstract  
Introduction: Although it is a well recognized premalignant lesion of the stomach, there is a dearth of information on the clinicopathologic 
features of gastric intestinal metaplasia in Nigerians. It is, therefore, necessary to study these features and their possible contribution to the 
development of gastric carcinoma in Nigerians. Methods: All gastric biopsies with the histo-morphologic features of intestinal metaplasia 
diagnosed at the department of morbid anatomy and forensic medicine, Obafemi Awolowo university teaching hospitals complex, Ile-Ife, Nigeria 
between January 2006 and December 2010 were used for the study. Results: A total of 165 biopsies (21.3% of all gastric biopsies within the 
study period) with background chronic gastritis and intestinal metaplasia were reviewed. The mean age of patients with intestinal metaplasia was 
50.3 years ± 17 standard deviation (SD) while the ages of the patients ranged from 10-100 years. There were 83 males (50.3%) with a mean age 
of 48.1 ± 18.2 SD years and 95% confidence interval (CI) of 44.1-52.1 years. There were, however, 82 females (49.6%) with a mean age of 52.5 
(± 15.8 SD) years and a 95% CI of 49.0-56.0 years. There was no significant association between the histologic type of intestinal metaplasia and 
the patients’ sex, age groups, severity of chronic gastritis, disease activity or degree of gastric glandular atrophy. Conclusion: There are no 
statistically significant differences in the clinicopathologic characteristics of the subtypes of intestinal metaplasia. In majority of patients, 
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Intestinal metaplasia of the gastric mucosa is a well recognized 
premalignant condition of the stomach that arises from a 
background of well established chronic atrophic gastritis due to 
various aetiological factors most significant of which is infection of 
the gastric mucosa by Helicobacter pylori. Many studies have since 
established a strong link between Helicobacter pylori, chronic 
gastritis and intestinal metaplasia. Nevertheless, there are other less 
frequent causes of this association. These include autoimmune 
gastritis, alcohol, cigarette smoking, radiation, Chron’s disease, 
uremia and graft-versus-host disease among others [1]. The chronic 
inflammation is believed to ultimately lead to glandular atrophy and 
intestinal metaplasia of the gastric mucosa which significantly 
increases the risk for the development of the intestinal type of 
gastric carcinoma. This intestinal metaplasia has been classified as 
complete, incomplete and mixed. 
  
Although there are no clearly defined sequences of genetic 
alterations that are thought to lead to the development of gastric 
adenocarcinoma from intestinal metaplasia, mutations of the E-
cadherin gene, transforming growth factor receptor ßII, p53, BAX, 
insulin-like growth factor receptor II have been associated with 
these events [2,3]. Efforts are, however, still on going to map out 
possible pathogenetic pathways where such exist. Various reports 
have been published on the necessity or otherwise of indicating the 
histological types of intestinal metaplasia [4-8]. Filipe et al, who 
conducted a cohort study on the subtypes of intestinal metaplasia 
and their relative risk for the development of gastric carcinoma in a 
Slovenian population, found some differences in the cancer risk 
between the various subtypes of intestinal metaplasia [9]. He thus 
supported the histological sub-typing of intestinal metaplasia as an 
integral part of the pathological assessment of chronic gastritis in 
gastric biopsies. [9] El Zimaity et al on the other hand, did not 
support this view since they did not find any significant advantage 
that doing so might confer on the patient’s relative cancer risk [10]. 
A lot of studies have investigated the possible relationships that 
exist between gastric carcinoma in Nigerians and some of the well 
known aetiological factors [11-16]. For example, Sabageh et 
al studied gastric carcinoma in Ile-Ife, Nigeria and found intestinal 
metaplasia in 56.7% of patients with gastric carcinoma, 40.7% of 
which were of the intestinal-type. [11] Most of these were found in 
the gastric antrum. The study emphasized the relationship of gastric 
carcinoma with intestinal metaplasia of the gastric mucosa. In 
Nigeria, there is a dearth of information on the pathology of gastric 
intestinal metaplasia, a well recognized premalignant lesion of the 
stomach, in contrast to the large volume of work done in other 
regions of the world which have clearly defined the characteristics of 
this lesion [11]. It is, therefore, necessary to study the clinical and 
pathological features of gastric intestinal metaplasia and the role it 
plays in the development of gastric carcinoma in Nigerians. The 
main objective of this study was, therefore, to evaluate the age, sex 
and histo-morphologic characteristics of patients with chronic 
gastritis and intestinal metaplasia and to compare the mean age of 
patients with intestinal metaplasia to that of patients with gastric 





This is a five-year retrospective study of all gastric biopsies with 
histologic features of chronic gastritis and intestinal metaplasia 
received at the Department of Morbid Anatomy and Forensic 
Medicine, Obafemi Awolowo University Teaching Hospitals Complex, 
Ile-Ife, Nigeria between January 1, 2006 to December 31, 2010. 
The patients’ original request cards were reviewed and the 
demographic data extracted. The surgical pathology reports were 
scrutinized while the histology slides were reviewed for details of 
the gross and microscopic characteristics respectively. The 
microscopic features assessed included the severity of the chronic 
inflammation, degree of specialized glandular atrophy, type of 
intestinal metaplasia and the presence or absence of dysplasia. The 
severity of chronic inflammation was graded as mild, moderate or 
marked according to the upgraded Sydney System [16]. The 
glandular atrophy was graded as absent, mild, moderate or marked 
using the same system. In addition, intestinal metaplasia was 
classified as complete or incomplete using the same updated 
Sydney system. The presence or absence of dysplasia was also 
assessed and classified as mild, moderate or marked where present. 
The data was analyzed for differences in proportion, using Chi 
square (p is significant at <0.05), with SPSS version 15.0. Student t-
test of equality of means was also performed. The data was 





Within the period under review a total of 775 cases of chronic 
gastritis were histologically diagnosed. However, only 165 cases 
(21.3%) showed histological features of intestinal metaplasia of 
which 137 were properly classified into complete or incomplete 
intestinal metaplasia. The other 28 biopsies were difficult to 
characterize due to severe crushing and fragmentation of the tissue 
sections. The mean age for the occurrence of intestinal metaplasia 
in gastric biopsies with background chronic gastritis was 50.3 years 
± 17.1 SD while the ages of the patients ranged from 10 -100 years 
(Figure 1). Table 1 shows the age distribution of the subtypes of 
intestinal metaplasia. Although the specific types of intestinal 
metaplasia were not significantly associated with the age of the 
patients (P=0.934), most of the cases of intestinal metaplasia 
occurred between the ages of 30-59 years. There were 83 males 
(50.3%) with a mean age of 48.1 years ± 18.2 SD and a 95% 
Confidence Interval (CI) of 44.1-52.1 years. There were, however, 
82 females (49.7%) with a mean age of 52.5 years ± 15.8 SD and a 
95% CI of 49.0-56.0 years. Thus the male to female ratio was 
approximately 1:1. Figure 2 is a box and whisker chart showing the 
difference in these means and the variation around the mean. There 
was however, no statistically significant difference in the mean ages 
of both sexes (t-test of equality of means, P=0.10). There were 78 
(47.3%) and 59 (35.8%) cases of incomplete and complete 
metaplasia respectively. The mean age of all the cases of 
incomplete intestinal metaplasia was 52.5 ± 16.6 years while that of 
complete intestinal metaplasia was 48.9 ± 17.5 years (Figure 3). 
There was no statistically significant difference in the mean ages for 
the sub-types of intestinal metaplasia (t-test of equality of means, 
P=0.217). Males accounted for 37 cases (47.4%) of incomplete 
metaplasia, while females accounted for 41 cases (52.6%). On the 
other hand, males accounted for 33 cases (55.9%) of complete 
metaplasia while females accounted for 26 cases (44.1%). 
histological features of intestinal metaplasia of which 137 were 
properly classified into complete or incomplete intestinal 
metaplasia.There was, however, no statistically significant 
association between the patients’ sex and the sub-type of intestinal 
metaplasia (P=0.325). Mild, moderate and marked chronic gastritis 
were respectively found in 10 (13.2%), 25 (32.9%) and 41 (53.9%) 
cases of incomplete intestinal metaplasia on one hand and in 3 
(5.2%), 23 (39.7%) and 32 (55.2%) cases of complete intestinal 
metaplasia on the other hand. The severity of the inflammation 
could not be determined in 3 of the cases with intestinal metaplasia 
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due to inadequate histologic material. The type of intestinal 
metaplasia was not significantly associated with the severity of 
chronic inflammation of the gastric mucosa (P=0.274). Mild, 
moderate and marked gastric glandular atrophy were found 
respectively in 28 (13.0%), 31 (40.3%) and 8 (10.4%) cases of 
incomplete intestinal metaplasia and in 13 (23.2%), 24 (42.9%) and 
10 (17.9%) cases of complete intestinal metaplasia. The type of 
intestinal metaplasia was however, not significantly associated with 
the degree of gastric glandular atrophy (P=0.331). There were only 





From this study it is evident that the there is no statistically 
significant difference in the clinical and histo-morphologic 
characteristics of complete and incomplete intestinal metaplasia. 
This study showed that there was no statistically significant 
association between the distinct subtypes of intestinal metaplasia 
and the patients’ age, sex, and the various histopathological 
parameters that characterize chronic gastritis as seen in their gastric 
biopsies. This study showed that the mean ages for patients with 
complete and incomplete intestinal metaplasia were similar. This 
probably suggests that both subtypes of intestinal metaplasia 
develop within similar time frames from the onset of chronic 
atrophic gastritis in these patients. Moreover, the fact that the 
degree of gastric glandular atrophy as well as the severity of the 
chronic mucosal inflammation did not significantly differ in patients 
with complete and incomplete intestinal metaplasia alsos uggest 
that similar pathogenetic mechanisms may underlie these changes. 
Although various opinions exist about the natural history for the 
development and progression of complete and incomplete intestinal 
metaplasia, our study, like many others, seems to suggest that it is 
highly probable that both subtypes may be quite similar in this 
regard histological features of intestinal metaplasia of which 137 
were properly classified into complete or incomplete intestinal 
metaplasia [5,6,9,10]. Our finding also supports the view that at the 
present moment it may not be clinically relevant to differentiate 
between complete and incomplete intestinal metaplasia [10]. 
Nevertheless, further studies need to be done in this geographic 
region to evaluate the relative risk for each subtype of intestinal 
metaplasia for the development of gastric carcinoma before final 
conclusions can be arrived at. 
  
Sabageh et al working at the same centre where this study was 
carried out had earlier reported the average age of patients with the 
intestinal type of gastric carcinomas to be 55 years [11]. This mean 
age is about 7 years older that the mean ages of patients with both 
complete and incomplete intestinal metaplasia as shown in this 
study. This may probably reflect the average time frame it takes for 
patients with chronic atrophic gastritis and intestinal metaplasia to 
progress to gastric carcinoma. This, therefore, suggests the need 
for a more vigorous and early screening program for patients with 
chronic atrophic gastritis and especially those who develop intestinal 
metaplasia in the course of the disease so as to forestall progression 
to gastric carcinoma. The mean age of males with intestinal 
metaplasia did not differ significantly from that of the female 
patients. This probably suggests similar aetiopathogenic 
mechanisms for chronic gastritis and therefore intestinal metaplasia 
in both sexes. It is possible that hormonal influences (including 
pregnancy) probably have little or no effect on the rate of 
development and progression of chronic gastritis and intestinal 
metaplasia [17]. Earlier reports from our centre have Earlier reports 
from our centre have shown that the male to female ratio of the 
intestinal type of gastric carcinoma was 1.2:1 in contrast to the 
diffuse type of gastric carcinoma which showed an equal sex 
distribution [11,12]. In fact, Sabageh et al in an earlier study found 
this slightly increased frequency of gastric carcinoma in males 
compared to females [11]. Our study, however, showed an equal 
sex distribution for intestinal metaplasia. This may suggest that 
there is a slightly increased likelihood of intestinal metaplasia 
progressing to gastric carcinoma in male patients. This perhaps may 
be due to certain, yet unknown, factors restricted to the male sex. It 
is necessary to conduct a more detailed study to elucidate the 
statistical significance of the differences between both sexes and 
the possible role that gender plays (if any) in the transition from 
intestinal metaplasia to gastric carcinoma. This study also showed 
that majority (56.1%) of chronic gastritis patients with intestinal 
metaplasia were between the ages of 30 and 60 years. The mean 
age from this study is much lower than those from other parts of 
the world. [7] It is possible that majority of our patients develop 
chronic gastritis at much younger ages. It is, therefore, necessary 
that screening, monitoring and appropriate treatments and follow- 
up programs are commenced as early as possible in these patients 
even in those younger than 30 years old.Interestingly, Sabageh et al 
in an earlier study from our centre reported that about 14% of the 
patients with the intestinal type of gastric carcinoma were younger 
than 40 years old [11]. Our study, however, found that 29.2% of 
patients with intestinal metaplasia were younger than 40 years old 
while 11.0% were below the age of 30 years. The existence of 
intestinal metaplasia in these very young groups of patients shows 
that it probably plays an important role in the pathogenesis of 
intestinal type of gastric carcinoma in such patients who develop 
gastric carcinoma before the age of 40 years. This observation 
further buttresses our earlier suggestion of an average transition 
period of 7 years between intestinal metaplasia and the 
development of gastric carcinoma. A large cohort study of patients 
with varying degrees of chronic gastritis may be required to further 
characterize this transition to gastric carcinoma. Although many 
studies have shown that the prevalence of intestinal metaplasia 
increases with age, our study showed that the frequency of cases of 
intestinal metaplasia decreased with advancing age [17]. This lower 
frequency among the older subjects may not be due to a reduction 
in the incidence of intestinal metaplasia, but may actually reflect the 
Nigerian population statistics which according to the 2006 
population census show a significantly lower proportion of 





There are no statistically significant differences between the clinical 
and histo-morphologic characteristics of complete and incomplete 
intestinal metaplasia in patients with chronic atrophic gastritis. It 
probably takes about 7 years for gastric carcinoma to develop in 
patients with intestinal metaplasia occurring in a background of 
chronic atrophic gastritis. Since a significant number of our patients 
develop intestinal metaplasia at an early age, early screening, 
monitoring and treatment programs are advocated. 
 
What is known about this topic 
 
• Intestinal metaplasia, a well recognized sequel to chronic 
atrophic gastritis, increases the risk for the development 
of gastric adenocarcinoma. 
• There are divergent views wirh regards to the relative 
risks of complete and incomplete intestinal metaplasia for 
the development of gastric adenocarcinoma. 
• There is paucity of information on the clinicopathologic 
characteristics of intestinal metaplasia among Nigerian 
patients. 
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What this study adds 
 
• Intestinal metaplasia develops at a much earlier age in 
Nigerian patients. 
• Progression from intestinal metaplasia to the development 
of gastric adenocarcinoma probably takes an average of 7 
years in Nigerian patients. 
• There are no statistically significant differences in the 
clinicopathologic characteristics of complete and 
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Table 1: age distribution of the subtypes of metaplasia 
Age group Metaplasia Total 
Incomplete Complete 
10-19 1(1.3%) 1(1.7%) 2(1.5%) 
20-29 7(9.0%) 6(10.2%) 13(9.5%) 
30-39 12(15.4%) 13(22.0%) 25(18.2%) 
40-49 14(17.9%) 10(16.9%) 24(17.5%) 
50-59 15(19.2%) 13(22.0%) 28(20.4%) 
60-69 15(19.2%) 7(11.9%) 22(16.1%) 
70-79 9(11.5%) 6(10.2%) 15(10.9%) 
80-89 4(5.1%) 3(5.1%) 7(5.1%) 
>90 1(1.3%) 0(0%) 1(0.7%) 








Figure 1: Age distribution of patients  
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sFigure 3: Box plot of patients’ age with complete and incomplete intestinal metaplasia 
 
 
